http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Boston Solar President Mike Morlino, MBA from MIT and a 20+ year Navy SEAL Shares Leadership Insights on Operator-to-Operator Podcast
-
Dare Bioscience (DARE) Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development
-
Applegate Farms, LLC Launches New Ready-to-Heat-and-Eat APPLEGATE NATURALS® Breakfast Sandwiches
-
Aqua Metals (AQMS) Strengthens Board of Directors to Advance Sustainable Battery Recycling and Critical Minerals Production
-
Allarity Therapeutics (ALLR) Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer
-
NV5 Global (NVEE) Awarded $5M in Substation Design Contracts by Northeast Utilities
-
Genomenon and Mirum Pharmaceuticals Join Forces to Enhance CTX Disease Awareness and Diagnosis
-
Dallas Accounting and Finance Executive Search Firm Expands
-
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development
-
Aqua Metals Strengthens Board of Directors to Advance Sustainable Battery Recycling and Critical Minerals Production
-
Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
-
Buyer Group International, Inc. Announces Phase 1b Soil Sampling and Geological Mapping Results, Outlines Next Steps
-
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS ADDS NEW VIRTUAL CARE OPTION TO SUPPORT WOMEN'S HEALTH
-
SFL Missions Inc. Awarded Canadian Space Agency Contract for HAWC Satellite Mission Conceptual Design Study
-
Cortechs.ai and EDAP Announce World’s First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center
-
Operation HOPE Releases 2024 National Impact Report Highlighting Continued Impressive Growth and Improved Client Outcomes
-
ESGold Launches First Ever Systematic Exploration of Montauban's District-Scale VMS Deposit
-
ReElement Technologies Begins Weekly Shipments of High Purity Rare Earth Elements to Secure a Domestic Critical Mineral Supply Chain
-
NV5 Awarded $5 Million in Substation Design Contracts by Northeast Utilities
-
Equillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis
-
Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer
-
The Identity Theft Resource Center Announces the Appointment of Michael Wong to its Board of Directors
-
Palatin Technologies (PTN) Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP Tirzepatide
-
Realbotix to Release its Q1-2025 Financial Results on February 13, 2025
-
Belden Reports Fourth Quarter and Full Year 2024 Results
-
DeFi Technologies Announces Attendance and Platinum Sponsorship of the Capital Markets Forum Riyadh 2025
-
Sokoman Provides Western Trend Update, Moosehead Gold Project, Central Newfoundland
-
Human Affairs International of California Earns Full Accreditation from the National Committee for Quality Assurance
-
Palatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP Tirzepatide
-
CytoMed Therapeutics announces Chairman’s Letter to the Company’s shareholders
-
O-I GLASS SEEKS TO POSITION HOLZMINDEN FOR STRONG FUTURE
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
2seventy bio (TSVT) Reports Preliminary Full-Year U.S. Abecma Sales
-
2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results
-
Lightspeed Commerce (LSPD) Announces Results of Strategic Review, Reports Q3 Results
-
Lightspeed Announces Results of Strategic Review and Third Quarter 2025 Financial Results
-
NEW POLICY AGENDA COVERS 14 CRITICAL ISSUES TO DEFEND WOMEN'S PROGRESS
-
PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease
-
NexGold Mining Corp. Presents in Red Cloud's Virtual Webinar Series
-
Fraud factories, cyber criminals and corruption: The Economist's new podcast, "Scam Inc", uncovers a new, global, underground economy worth more than illicit drug trade
-
Lightbridge CEO Seth Grae to Participate in Key Nuclear Industry Events in February
-
Descartes Systems Group (DSGX) Showcases Global Trade Intelligence Technology Innovations
-
Descartes Showcases Global Trade Intelligence Technology Innovations
-
Merck (MRK) Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin
-
Avino Provides 2025 Outlook and Highlights 2024 Achievements
-
Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large
-
Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis
-
Zimmer Biomet Announces Fourth Quarter and Full-Year 2024 Financial Results
-
Texas Mineral Resources Chairman Anthony Marchese Invited to Testify at the U.S. Senate Committee on Commerce, Science & Transportation Hearing on February 12th
-
REEV Raises $9.2M to Revolutionize Mobility Assistance for Patients with Gait Disorders
